Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4208702
Max Phase: Preclinical
Molecular Formula: C21H15F2N5O
Molecular Weight: 391.38
Molecule Type: Small molecule
Associated Items:
ID: ALA4208702
Max Phase: Preclinical
Molecular Formula: C21H15F2N5O
Molecular Weight: 391.38
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: Cc1cccc(NC(=O)c2cc(C(F)(F)c3cncnc3)cc3cccnc23)n1
Standard InChI: InChI=1S/C21H15F2N5O/c1-13-4-2-6-18(27-13)28-20(29)17-9-15(8-14-5-3-7-26-19(14)17)21(22,23)16-10-24-12-25-11-16/h2-12H,1H3,(H,27,28,29)
Standard InChI Key: KNAHDUUYZKYKDO-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 391.38 | Molecular Weight (Monoisotopic): 391.1245 | AlogP: 4.12 | #Rotatable Bonds: 4 |
Polar Surface Area: 80.66 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 6 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 13.82 | CX Basic pKa: 3.53 | CX LogP: 3.16 | CX LogD: 3.16 |
Aromatic Rings: 4 | Heavy Atoms: 29 | QED Weighted: 0.57 | Np Likeness Score: -1.49 |
1. Felts AS, Rodriguez AL, Morrison RD, Blobaum AL, Byers FW, Daniels JS, Niswender CM, Conn PJ, Lindsley CW, Emmitte KA.. (2018) Discovery of 6-(pyrimidin-5-ylmethyl)quinoline-8-carboxamide negative allosteric modulators of metabotropic glutamate receptor subtype 5., 28 (10): [PMID:29705142] [10.1016/j.bmcl.2018.04.053] |
Source(1):